Skip to main content
. Author manuscript; available in PMC: 2023 Jan 12.
Published in final edited form as: J Vasc Surg. 2021 Apr 2;74(4):1232–1239.e3. doi: 10.1016/j.jvs.2021.03.017

Table II.

Description of treated diabetic limbs stratified by quartile of estimated likelihood of benefit of revascularization

Variable Overall Q1 (highest
benefit)
Q2 (moderate
benefit)
Q3 (low
benefit)
Q4 (questionable
benefit)
P value
Limbs treated, No. 187 (100) 51 (27.3) 59 (31.6) 38 (20.3) 39 (20.9) NA
WIfI stage <.001
 1 12 (6.4) 0 (0) 0 (0) 11 (29.0) 1 (2.6)
 2 18 (9.6) 0 (0) 7 (11.9) 9 (23.7) 2 (5.1)
 3 45 (24.1) 18 (35.3) 10 (17.0) 16 (42.1) 1 (2.6)
 4 112 (59.9) 33 (64.7) 42 (71.2) 2 (5.3) 35 (89.7)
Revascularization approach .09
 Endovascular 125 (66.8) 37 (72.6) 32 (54.2) 29 (76.3) 27 (69.2)
 Open surgery 62 (33.2) 14 (27.5) 27 (45.8) 9 (23.7) 12 (30.8)

NA, Not applicable; Q, quartile; WIfI, Wound, Ischemia, and foot Infection.

Data presented as number (%).